Text Size

A multicenter randomized controlled study of antioxidant supplementation with lutein for chronic central serous chorioretinopathy

Shinojima A., Sawa M., Sekiryu T., Oshima Y., Mori R., Hara C., Sugano Y., Kato A., Asato H., Yuzawa M., Gomi F., Ogura Y., Ishibashi T., Nanri T., Yasukawa T.

  • 2017
  • Ophthalmologica
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Clinical development

  • Affiliations

    Division of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine, Tokyo, Japan; Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan; Santen Pharmaceutical Co., Ltd., Osaka, Japan

Related Publications

Aging-associated changes of optical coherence tomography-measured ganglion cell-related retinal layer thickness and visual sensitivity in normal Japanese

Iwase A., Higashide T., Fujii M., Ohno Y., Tanaka Y., Kikawa T., Araie M.

Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study

Chia A, Ngo C, Choudry N, Yamakawa Y, Tan D

Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial

Yoshida T.; Takagi Y.; Igarashi-Yokoi T.; Ohno-Matsui K.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022